NanoGroup S.A. (WSE:NNG)
Poland
· Delayed Price · Currency is PLN 2.540
+0.015 (0.59%)
Mar 9, 2026, 4:49 PM CET
NanoGroup Company Description
NanoGroup S.A. operates as a biotechnology company in Poland.
It engages in the production of medicines and other pharmaceutical products, and research and development work in the field of biotechnology and other natural and technical sciences.
The company is also involved in technical research and analysis. In addition, it manages a portfolio of companies that manage projects to meet the needs of modern medicine in the field of oncology and transplantology.
The company was founded in 2016 and is based in Warsaw, Poland.
NanoGroup S.A.
| Country | Poland |
| Founded | 2016 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Przemyslaw Mazurek |
Contact Details
Address: ul. Rakowiecka 36 Warsaw, 02-532 Poland | |
| Phone | 48 604 74 13 03 |
| Website | nanogroup.eu |
Stock Details
| Ticker Symbol | NNG |
| Exchange | Warsaw Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | PLN |
| ISIN Number | PLNNGRP00011 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Przemyslaw Daniel Mazurek | President of the Management Board |
| Piotr Pietrzak | Vice President of the Management Board |
| Prof. Tomasz Adam Ciach | Founder and Member of the Management Board |
| Anna Redwan | Chief of Corporate Affairs and Communications |